您的位置: 首页 > 农业专利 > 详情页

5-hydroxy-1H-imidazole-4-carboxamide effective-dose/sensitivity prediction method and prediction device, xanthosine-monophosphate-amount measurement method, and myelodysplastic-syndrome treatment agent and treatment method
专利权人:
FUJIFILM Corporation
发明人:
MURASE, Motohiko,MATSUSHITA, Minako,KOMATSU, Kensuke,WATANABE, Kumiko,KUWATA, Yusuke,TAKEO, Atsushi,YAMASHITA, Ryo
申请号:
AU2018202975
公开号:
AU2018202975A1
申请日:
2018.04.30
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
#$%^&*AU2018202975A120180517.pdf#####ABSTRACT An object of the present invention is to provide a method and apparatus for predicting an effective dose of or the sensitivity to 5-hydroxy-1H-imidazole-4-carboxamide, which are capable of performing a determination in a simple operation and a short time, a method for determining amounts of xanthosine monophosphate, and a treatment agent and treatment method for treating myelodysplastic syndrome. According to the present invention, provided are a method for predicting an effective dose of or the sensitivity to 5-hydroxy-11-imidazole-4-carboxamide, including determining amounts of xanthosine monophosphate in blood and a prediction apparatus, a method for determining amounts of xanthosine monophosphate, including determining xanthosine monophosphate in blood in two different determining conditions by mass spectrometry, and a treatment agent and treatment method for treating myelodysplastic syndrome.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充